EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Marizyme, Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -39.25. In total, the insiders bought 14 345 054 and sold 7 083 526 MRZM shares in the last 100 trades.

Insider Power

(Last 100 transactions)
-39.25
Buy 14 345 054 Shares
Sell 7 083 526 Shares

Historical Insider Trades

Date Type Action Person Amount
Mar 05, 2024 Options Buy Kampf Julie B. 125 000
Mar 04, 2024 Options Buy Dhaduk Vithalbhai D 125 000
Dec 21, 2023 Common stock Sell Braeden Lichti 3 815 294
Dec 21, 2023 10% Secured Convertible Promissory Note Sell Braeden Lichti 2
Nov 30, 2023 Options Buy Brooks Steven Scott 40 000
Nov 30, 2023 Options Buy Very Donald Leroy Jr 40 000
Oct 31, 2023 Options Buy Campbell Neil J 500 000
Aug 29, 2023 Common shares Sell Lichti Braeden 105 000
Aug 29, 2023 Common shares Sell Lichti Braeden 105 000
Jul 07, 2023 Common shares Sell Lichti Braeden 97 000
Jul 07, 2023 Common shares Sell Lichti Braeden 97 000
Jun 29, 2023 Common shares Sell Lichti Braeden 106 327
Jun 29, 2023 Common shares Sell Lichti Braeden 106 327
Apr 14, 2023 Common Stock Buy Dhaduk Vithalbhai D 1 063 938
Apr 14, 2023 Warrant (right to buy) Buy Dhaduk Vithalbhai D 1 063 938
Apr 14, 2023 Warrant (right to buy) Sell Dhaduk Vithalbhai D 1 063 938
Apr 14, 2023 Warrant (right to buy) Sell Dhaduk Vithalbhai D 1 063 938
Jun 07, 2022 Stock Option (right to buy) Buy Stewart Michael R 120 000
Jun 07, 2022 Stock Option (right to buy) Buy Stewart Michael R 120 000
Jun 07, 2022 Stock Option (right to buy) Buy Brostowin Terry A 40 000
Jun 07, 2022 Stock Option (right to buy) Buy Hearl William 40 000
Jun 07, 2022 Stock Option (right to buy) Buy Dhaduk Vithalbhai D 40 000
Jun 07, 2022 Stock Option (right to buy) Buy Dhaduk Vithalbhai D 40 000
Jun 07, 2022 Buy Patel Nilesh Umedbhai 0
Jun 07, 2022 Stock Option (right to buy) Buy Kampf Julie B. 40 000
Click to get the best stock tips daily for free!

About Marizyme, Inc.

Marizyme. Marizyme, Inc., a life science company, engages in the development and commercialization of medical technologies business. It offers DuraGraft, a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, and other related properties. The company also develops various products using its Krillase protease-based therapeutic platform for treating complex wounds and bur... MRZM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT